Clinical Trials Details

EAY191 ComboMATCH (Any Cancer)

Molecular Analysis for Combination Therapy Choice (ComboMATCH) - Registration Trial, then enrolls to ComboMATCH Treatment Trials based on genomic data/targeted agents

Objective

Key eligibility: Measurable disease, ECOG 0-2, sequencing results available, potentially eligible for a treatment trial

» Learn more about this trial

Clinical Trial Categories

• Cancers and Other Neoplasms